论文 · 动物实验
一种主动免疫训练策略以产生针对病毒逃逸的预适应性免疫
A proactive immune training strategy to generate anticipatory immunity against viral evasion
作者:Shugang Qin, Yuqin Teng, Jinxiu Xin, Yupei Zhang, Letao Huang, Siyu Zhao, Xiangyu Jiao, Xiaoling Yin, Shenbin Liu, Ju Sun, Weitong Xu, Yongmei Xie 等 15 人
J Adv Res · 2026年9月8日 · Qin 等 15 位作者
不需要生物学背景,多打比方
正在获取全文并生成讲解(拿不到全文就依据摘要),大约需要 30–60 秒…
已等待 0 秒
这篇还没有动画
动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要 30–60 秒。
摘要Abstract
INTRODUCTION: RNA viruses rapidly evolve to evade host immunity, posing a significant challenge to conventional vaccines. Natural infection, however, provides a blueprint for broad immunity by training the immune system against a diverse antigenic landscape. This study addresses the problem of creating a vaccine that mimics this complex training process.
OBJECTIVES: We aimed to develop and validate a novel vaccination paradigm, "Proactive Immune Training" (PIT), designed to enhance cross-reactive neutralization breadth against variants within the predicted evolutionary space.
METHODS: Using SARS-CoV-2 as a model, we constructed a 600-mutant mRNA library (m-library) based on 30 predicted high-frequency mutation sites. This library was encapsulated in proprietary lipid nanoparticles (LNPs) to form the PIT vaccine. We then evaluated a sequential prime-boost regimen consisting of a single-antigen (SA) vaccine followed by a PIT boost (SA + PIT) in BALB/c mice, assessing humoral and cellular immunity, and performing deep sequencing of B-cell and T-cell receptor repertoires.
RESULTS: The SA + PIT regimen induced significantly broader and more potent neutralizing antibodies against a range of SARS-CoV-2 variants compared to conventional regimens. This enhanced protection was mechanistically linked to a profound diversification of the T-cell and B-cell receptor repertoires, a hallmark of superior immune adaptability.
CONCLUSION: The PIT strategy successfully guides the immune system to generate a broad and adaptive immunological response. This proactive, training-based paradigm offers a powerful and versatile framework for developing next-generation vaccines against highly variable pathogens.
还没有查过关联研究
我会去找这篇研究之前的基础工作、做类似事情的研究,以及之后引用它的研究,并说明每篇为什么相关。